Skip to main content

Table 1 Demographic Characteristics of Survey Respondents

From: Clinical leaders and providers’ perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs’ facilities

 

Baseline (n = 56)

Follow-up (n = 61)

 

n

%

n

%

p-valuea

Survey Response per regional network, Mdn (Range)

3

1–7

3

0–8

 

Age:

    

0.92

 25–34

11

19.6

11

18.6

 

 35–44

20

35.7

18

30.5

 

 45–54

12

21.4

15

25.4

 

 55–64

9

16.1

12

20.3

 

 65 + 

4

7.1

3

5.1

 

Gender:

    

0.81

 Female

33

58.9

34

56.7

 

 Male

23

41.1

26

43.3

 

Total years of practice:

    

0.70

 ≤ 5

9

16.1

6

9.8

 

 5–10

14

25.0

19

31.1

 

 11–20

15

26.8

18

29.5

 

 20 + 

18

32.1

18

29.5

 

Race/Ethnicity:

    

0.52

 Asian

9

16.4

7

11.7

 

 Black or African American

5

9.1

6

10.0

 

 Hispanic or Latino

4

7.3

1

1.7

 

 Multiple ethnicity / Other

4

7.3

7

11.7

 

 White/Caucasian

33

60.0

39

65.0

 

Discipline:

    

0.58

 Physician

18

32.1

25

41.7

 

 Nurse Practitioner

8

14.3

4

6.7

 

 Psychologist/Social Worker/Addictions Therapist

10

17.9

9

15.0

 

 Pharmacist

9

16.1

12

20.0

 

 Nurse

11

19.6

10

16.7

 

Specialty:

    

0.98

 Mental Health

21

37.5

25

41.0

 

 Pain Management

16

28.6

17

27.9

 

 Primary care/general internal medicine

16

28.6

16

26.2

 

 Multiple or Other

3

5.4

3

4.9

 

Provider:

 Prescriber

26

46.4

28

45.9

0.95

 DEA Waivered

21

80.8

27

96.4

0.07

Prescribed Buprenorphine for OUD past year

13

61.9

20

74.1

0.37

  1. Mdn Median, DEA Waivered Drug Enforcement Agency Waiver to prescribe MOUD
  2. *p < .05
  3. aBased on Chi Square or Kruskal–Wallis tests for categorical and continuous variables, respectively